Teichos Laboratories, LLC. (Teichos) is a business-to-business biotechnology company that employs chemoenzymatic synthesis to access its platform of macromolecular biologics for diverse applications in immunotherapy and vaccine development. Collectively, Teichos members possess deep experience in human and veterinary drug development with start-up and large pharmaceutical organizations. Teichos partners with academic collaborators to generate proof-of-concept data for specific disease applications with the goal to establish developmental agreements with immunotherapy-focused partners for commercialization. Our products offer disruptive innovation in immunotherapy with broad applications in human and animal disease prevention and treatment.